UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000012233
Receipt No. R000014265
Official scientific title of the study Effects of Increasing Dose of Calcium Channel Blockers for Insufficiently Controlled Hypertension
Date of disclosure of the study information 2013/11/08
Last modified on 2017/07/24 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of Increasing Dose of Calcium Channel Blockers for Insufficiently Controlled Hypertension
Title of the study (Brief title) AIMIX study
Region
Japan

Condition
Condition Hypertension
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate effects of AIMIX on blood pressure and Hba1c
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Home blood pressure
Key secondary outcomes Hba1c, Urine albumin

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 AIMIX
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients with hypertension that are insufficiently treated with medication of ARBs and calcium channel blockers
Key exclusion criteria Patients with insufficient treatment on diabetes mellitus

Pregnant women

Patients that are recognized as inappropriate for this study
Target sample size 100

Research contact person
Name of lead principal investigator Shinya Minatoguchi
Organization Gifu University Graduate School of Medicine
Division name Department of Cardiology
Address 1-1 Yanagido, Gifu
TEL 058-230-6523
Email minatos@gifu-u.ac.jp

Public contact
Name of contact person Shinya Minatoguchi
Organization Gifu University Graduate School of Medicine
Division name Department of Cardiology
Address 1-1 Yanagido, Gifu
TEL 058-230-6523
Homepage URL
Email minatos@gifu-u.ac.jp

Sponsor
Institute Department of Cardiology, Gifu University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Cardiology, Gifu University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 11 Month 08 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 11 Month 01 Day
Anticipated trial start date
2013 Year 11 Month 08 Day
Last follow-up date
2016 Year 05 Month 31 Day
Date of closure to data entry
2016 Year 05 Month 31 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 11 Month 07 Day
Last modified on
2017 Year 07 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014265